Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16
Applied DNA Sciences, Inc. (NASDAQ:APDN) has announced its participation in the 2024 Maxim Healthcare Virtual Summit. The company's president and CEO, Dr. James A. Hayward, will engage in a fireside chat on Wednesday, October 16, 2024, at 12:50 p.m. EDT. This virtual event, hosted by Maxim Group , runs from October 15th to 17th.
The interview will be conducted by Jason McCarthy, Ph.D., Maxim's senior managing director and head of Biotechnology Research. Registered conference attendees will have access to view Applied DNA's fireside chat. Applied DNA, known for its leadership in PCR-based DNA technologies, will use this platform to share insights with the healthcare investment community.
Applied DNA Sciences, Inc. (NASDAQ:APDN) ha annunciato la sua partecipazione al 2024 Maxim Healthcare Virtual Summit. Il presidente e CEO dell'azienda, Dr. James A. Hayward, parteciperà a una conversazione informale il mercoledì 16 ottobre 2024, alle 12:50 EDT. Questo evento virtuale, ospitato da Maxim Group, si svolgerà dal 15 al 17 ottobre.
L'intervista sarà condotta da Jason McCarthy, Ph.D., direttore senior e capo della ricerca nel settore biotecnologico di Maxim. I partecipanti registrati alla conferenza avranno accesso per visualizzare la conversazione informale di Applied DNA. Applied DNA, nota per il suo leadership nelle tecnologie DNA basate su PCR, utilizzerà questa piattaforma per condividere intuizioni con la comunità degli investimenti nel settore sanitario.
Applied DNA Sciences, Inc. (NASDAQ:APDN) ha anunciado su participación en la Cumbre Virtual de Atención Médica Maxim 2024. El presidente y CEO de la compañía, Dr. James A. Hayward, participará en una charla informal el miércoles 16 de octubre de 2024, a las 12:50 p.m. EDT. Este evento virtual, organizado por Maxim Group, se llevará a cabo del 15 al 17 de octubre.
La entrevista será conducida por Jason McCarthy, Ph.D., director senior y jefe de Investigación en Biotecnología de Maxim. Los asistentes registrados a la conferencia podrán acceder a la charla informal de Applied DNA. Applied DNA, conocida por su liderazgo en tecnologías de ADN basadas en PCR, utilizará esta plataforma para compartir conocimientos con la comunidad de inversión en atención médica.
Applied DNA Sciences, Inc. (NASDAQ:APDN)는 2024 Maxim Healthcare Virtual Summit에 참여한다고 발표했습니다. 회사의 사장 겸 CEO인 Dr. James A. Hayward는 2024년 10월 16일 수요일 오후 12시 50분 EDT에 대화 형식의 토론에 참석할 예정입니다. Maxim Group이 주최하는 이번 가상 이벤트는 10월 15일부터 17일까지 진행됩니다.
인터뷰는 Maxim의 선임 전무이사이자 생명공학 연구 책임자인 Jason McCarthy, Ph.D.가 진행합니다. 등록된 컨퍼런스 참석자는 Applied DNA의 대화 형식 토론을 시청할 수 있습니다. PCR 기반 DNA 기술에서의 리더십으로 잘 알려진 Applied DNA는 이번 플랫폼을 활용하여 의료 투자 커뮤니티와 인사이트를 공유할 것입니다.
Applied DNA Sciences, Inc. (NASDAQ:APDN) a annoncé sa participation au Sommet Virtuel de Soins de Santé Maxim 2024. Le président et directeur général de l'entreprise, Dr. James A. Hayward, participera à une discussion informelle le mercredi 16 octobre 2024, à 12h50 EDT. Cet événement virtuel, accueilli par Maxim Group, se déroulera du 15 au 17 octobre.
L'entretien sera mené par Jason McCarthy, Ph.D., directeur général senior et responsable de la recherche en biotechnologie chez Maxim. Les participants enregistrés à la conférence auront accès à la discussion informelle de Applied DNA. Applied DNA, reconnue pour son leadership dans les technologies ADN basées sur la PCR, utilisera cette plateforme pour partager des informations avec la communauté des investissements dans le secteur de la santé.
Applied DNA Sciences, Inc. (NASDAQ:APDN) hat seine Teilnahme am 2024 Maxim Healthcare Virtual Summit bekannt gegeben. Der Präsident und CEO des Unternehmens, Dr. James A. Hayward, wird am Mittwoch, den 16. Oktober 2024, um 12:50 Uhr EDT an einem Gespräch teilnehmen. Diese virtuelle Veranstaltung, die von Maxim Group ausgerichtet wird, findet vom 15. bis 17. Oktober statt.
Das Interview wird von Jason McCarthy, Ph.D., dem Senior Managing Director und Leiter der Biotechnologieforschung bei Maxim, durchgeführt. Registrierte Konferenzteilnehmer haben Zugang, um das Gespräch von Applied DNA anzusehen. Applied DNA, bekannt für ihre Führung in PCR-basierten DNA-Technologien, wird diese Plattform nutzen, um Einblicke in die Gesundheitsinvestitionsgemeinschaft zu teilen.
- None.
- None.
STONY BROOK, NY / ACCESSWIRE / October 15, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA"), a leader in PCR-based DNA technologies, today announced that Dr. James A. Hayward, president and chief executive officer, will participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit. Maxim Group LLC is presenting the virtual summit from October 15th to 17th.
Jason McCarthy, Ph.D., Maxim's senior managing director and head of Biotechnology Research, will interview Dr. Hayward.Applied DNA's fireside chat will be available for viewing by registered conference attendees on Wednesday, October 16, 2024.
Details for the fireside chat are as follows:
Date: Wednesday, October 16, 2024
Time: 12:50 p.m. EDT
Presenter: James A. Hayward, president and chief executive officer of Applied DNA
Registration: link
About Applied DNA Sciences
Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("DNA"). Using the polymerase chain reaction ("PCR") to enable both the production and detection of DNA, we operate in three primary business markets: (i) the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNA polymerase ("RNAP") for use in the production of mRNA therapeutics; (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.
Visit adnas.com for more information. Follow us on X and LinkedIn. Join our mailing list.
Contacts:
Investor Relations contact: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com
Web: www.adnas.com
X: @APDN
SOURCE: Applied DNA Sciences
View the original press release on accesswire.com
FAQ
When is Applied DNA (APDN) participating in the 2024 Maxim Healthcare Virtual Summit?
Who will represent Applied DNA (APDN) at the 2024 Maxim Healthcare Virtual Summit?
What is the format of Applied DNA's (APDN) presentation at the 2024 Maxim Healthcare Virtual Summit?
How can investors view Applied DNA's (APDN) fireside chat at the 2024 Maxim Healthcare Virtual Summit?
